Barlow’s Disease: Treating the Chords, Not the Leaflets, Is Key

A new study from Cleveland Clinic reveals how SGLT-2 inhibitors may increase the risk of adverse urologic side effects.

Learn how we’re expanding CAD management options for special patient populations through innovative offerings for microvascular disease and abundant clinical trial opportunities for elevated Lp(a)

Listen to a roundtable discussion on innovative approaches to facial plastic surgery, managing patient expectations and more in a recent episode of Cleveland Clinic’s Head…

The first in the U.S. to perform single-port robotic urologic surgery, Cleveland Clinic has performed over 1,000 SP surgeries since 2018.

Studies continue to indicate effectiveness and safety of losartan eye drops to eliminate corneal scarring.

“Controlling cancer is, of course, the goal, but there must also be a greater emphasis on life after treatment,” says Cleveland Clinic urologic oncologist Laura…

To refine deep brain stimulation for stroke recovery, we’re using calcium-based imaging to record neuronal activity in ischemia models. The goal is more personalized DBS…

Two of our heart surgeons feel a special responsibility to advocate for female patients and mentor the next generation of women in cardiac surgery.

Patients with new papulovesicular or vesiculopustular lesions should be screened for mpox.

A new study by Cleveland Clinic researchers finds nocturnal hypoxemia may be a cause of sarcopenia.